APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadoterate Meglumine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gadoterate Meglumine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025171 pages

Choose your research edition.

Industry ResearchGadoterate Meglumine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadoterate Meglumine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Gadoterate Meglumine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadoterate Meglumine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadoterate Meglumine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gadoterate Meglumine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gadoterate Meglumine include Hengrui Medicine, Guerbet Group and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadoterate Meglumine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadoterate Meglumine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadoterate Meglumine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadoterate Meglumine market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadoterate Meglumine Segment by Company

Hengrui Medicine

Guerbet Group

GE Healthcare

Gadoterate Meglumine Segment by Type

5.6535Gm/15Ml

3.769Gm/10Ml

1.8845Gm/5Ml

Others

Gadoterate Meglumine Segment by Application

Hospitals

Clinics

Gadoterate Meglumine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadoterate Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadoterate Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadoterate Meglumine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadoterate Meglumine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gadoterate Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gadoterate Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gadoterate Meglumine Industry Trends Table 2. Gadoterate Meglumine Industry Drivers Table 3. Gadoterate Meglumine Industry Opportunities and Challenges Table 4. Gadoterate Meglumine Industry Restraints Table 5. Global Gadoterate Meglumine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gadoterate Meglumine Sales by Manufacturers (K L) & (2021-2026) Table 8. Global Gadoterate Meglumine Sales Market Share by Manufacturers Table 9. Global Gadoterate Meglumine Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global Gadoterate Meglumine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gadoterate Meglumine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gadoterate Meglumine Manufacturers, Product Type & Application Table 13. Global Gadoterate Meglumine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadoterate Meglumine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5.6535Gm/15Ml Table 17. Major Manufacturers of 3.769Gm/10Ml Table 18. Major Manufacturers of 1.8845Gm/5Ml Table 19. Major Manufacturers of Others Table 20. Global Gadoterate Meglumine Sales by Type 2021 VS 2025 VS 2032 (K L) Table 21. Global Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 22. Global Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 23. Global Gadoterate Meglumine Sales Market Share by Type (2021-2026) Table 24. Global Gadoterate Meglumine Sales Market Share by Type (2027-2032) Table 25. Global Gadoterate Meglumine Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 26. Global Gadoterate Meglumine Revenue by Type (2021-2026) & (K L) Table 27. Global Gadoterate Meglumine Revenue by Type (2027-2032) & (K L) Table 28. Global Gadoterate Meglumine Revenue Market Share by Type (2021-2026) Table 29. Global Gadoterate Meglumine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinics Table 32. Global Gadoterate Meglumine Sales by Application 2021 VS 2025 VS 2032 (K L) Table 33. Global Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 34. Global Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 35. Global Gadoterate Meglumine Sales Market Share by Application (2021-2026) Table 36. Global Gadoterate Meglumine Sales Market Share by Application (2027-2032) Table 37. Global Gadoterate Meglumine Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 38. Global Gadoterate Meglumine Revenue by Application (2021-2026) & (K L) Table 39. Global Gadoterate Meglumine Revenue by Application (2027-2032) & (K L) Table 40. Global Gadoterate Meglumine Revenue Market Share by Application (2021-2026) Table 41. Global Gadoterate Meglumine Revenue Market Share by Application (2027-2032) Table 42. Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 43. Global Gadoterate Meglumine Sales by Region (2021-2026) & (K L) Table 44. Global Gadoterate Meglumine Sales Market Share by Region (2021-2026) Table 45. Global Gadoterate Meglumine Sales Forecasted by Region (2027-2032) & (K L) Table 46. Global Gadoterate Meglumine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 48. North America Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 49. North America Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 50. Europe Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 51. Europe Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 52. Europe Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 53. Asia Pacific Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 54. Asia Pacific Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 55. Asia Pacific Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 56. South America, Middle East and Africa Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 57. South America, Middle East and Africa Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 58. South America, Middle East and Africa Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 59. Global Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Gadoterate Meglumine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Gadoterate Meglumine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Gadoterate Meglumine Revenue Market Share by Region (2021-2026) Table 63. Global Gadoterate Meglumine Revenue Market Share by Region (2027-2032) Table 64. Hengrui Medicine Company Information Table 65. Hengrui Medicine Business Overview Table 66. Hengrui Medicine Gadoterate Meglumine Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Hengrui Medicine Gadoterate Meglumine Product Portfolio Table 68. Hengrui Medicine Recent Development Table 69. Guerbet Group Company Information Table 70. Guerbet Group Business Overview Table 71. Guerbet Group Gadoterate Meglumine Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Guerbet Group Gadoterate Meglumine Product Portfolio Table 73. Guerbet Group Recent Development Table 74. GE Healthcare Company Information Table 75. GE Healthcare Business Overview Table 76. GE Healthcare Gadoterate Meglumine Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GE Healthcare Gadoterate Meglumine Product Portfolio Table 78. GE Healthcare Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Gadoterate Meglumine Distributors List Table 82. Gadoterate Meglumine Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Gadoterate Meglumine Product Image Figure 2. Global Gadoterate Meglumine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadoterate Meglumine Market Size (2021-2032) & (US$ Million) Figure 4. Global Gadoterate Meglumine Sales (2021-2032) & (K L) Figure 5. Global Gadoterate Meglumine Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 Gadoterate Meglumine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5.6535Gm/15Ml Image Figure 9. 3.769Gm/10Ml Image Figure 10. 1.8845Gm/5Ml Image Figure 11. Others Image Figure 12. Global Gadoterate Meglumine Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 13. Global Gadoterate Meglumine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Gadoterate Meglumine Sales Market Share by Type (2021-2032) Figure 15. Global Gadoterate Meglumine Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 16. Global Gadoterate Meglumine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Gadoterate Meglumine Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Global Gadoterate Meglumine Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 21. Global Gadoterate Meglumine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Gadoterate Meglumine Sales Market Share by Application (2021-2032) Figure 23. Global Gadoterate Meglumine Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 24. Global Gadoterate Meglumine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Gadoterate Meglumine Revenue Market Share by Application (2021-2032) Figure 26. North America Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 27. North America Gadoterate Meglumine Sales Market Share by Country (2021-2032) Figure 28. U.S. Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 29. Canada Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 30. Mexico Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 31. Europe Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 32. Europe Gadoterate Meglumine Sales Market Share by Country (2021-2032) Figure 33. Germany Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 34. France Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 35. U.K. Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 36. Italy Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 37. Netherlands Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 38. Asia Pacific Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 39. Asia Pacific Gadoterate Meglumine Sales Market Share by Country (2021-2032) Figure 40. China Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 41. Japan Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 42. South Korea Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 43. Southeast Asia Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 44. India Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 45. Australia Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 46. South America, Middle East and Africa Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 47. South America, Middle East and Africa Gadoterate Meglumine Sales Market Share by Country (2021-2032) Figure 48. Brazil Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 49. South Africa Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 50. Saudi Arabia Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 51. Turkey Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 52. Argentina Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 53. UAE Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 54. Egypt Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 55. Chile Gadoterate Meglumine Sales and Growth Rate (2021-2032) & (K L) Figure 56. Global Gadoterate Meglumine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Gadoterate Meglumine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Figure 59. North America Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Gadoterate Meglumine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Gadoterate Meglumine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5.6535Gm/15Ml
  • 3.769Gm/10Ml
  • 1.8845Gm/5Ml
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hengrui Medicine
  • Guerbet Group
  • GE Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gadoterate Meglumine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gadoterate Meglumine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gadoterate Meglumine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gadoterate Meglumine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gadoterate Meglumine Market Dynamics
  1. 2.1 Gadoterate Meglumine Industry Trends
  2. 2.2 Gadoterate Meglumine Industry Drivers
  3. 2.3 Gadoterate Meglumine Industry Opportunities and Challenges
  4. 2.4 Gadoterate Meglumine Industry Restraints
3 Gadoterate Meglumine Market by Manufacturers
  1. 3.1 Global Gadoterate Meglumine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gadoterate Meglumine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gadoterate Meglumine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gadoterate Meglumine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gadoterate Meglumine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gadoterate Meglumine Manufacturers, Product Type & Application
  7. 3.7 Global Gadoterate Meglumine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gadoterate Meglumine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gadoterate Meglumine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gadoterate Meglumine Tier 1, Tier 2, and Tier 3
4 Gadoterate Meglumine Market by Type
  1. 4.1 Gadoterate Meglumine Type Introduction
  2. 4.1.1 5.6535Gm/15Ml
  3. 4.1.2 3.769Gm/10Ml
  4. 4.1.3 1.8845Gm/5Ml
  5. 4.1.4 Others
  6. 4.2 Global Gadoterate Meglumine Sales by Type
  7. 4.2.1 Global Gadoterate Meglumine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gadoterate Meglumine Sales by Type (2021-2032)
  9. 4.2.3 Global Gadoterate Meglumine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Gadoterate Meglumine Revenue by Type
  11. 4.3.1 Global Gadoterate Meglumine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Gadoterate Meglumine Revenue by Type (2021-2032)
  13. 4.3.3 Global Gadoterate Meglumine Revenue Market Share by Type (2021-2032)
5 Gadoterate Meglumine Market by Application
  1. 5.1 Gadoterate Meglumine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Gadoterate Meglumine Sales by Application
  5. 5.2.1 Global Gadoterate Meglumine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gadoterate Meglumine Sales by Application (2021-2032)
  7. 5.2.3 Global Gadoterate Meglumine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Gadoterate Meglumine Revenue by Application
  9. 5.3.1 Global Gadoterate Meglumine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gadoterate Meglumine Revenue by Application (2021-2032)
  11. 5.3.3 Global Gadoterate Meglumine Revenue Market Share by Application (2021-2032)
6 Global Gadoterate Meglumine Sales by Region
  1. 6.1 Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadoterate Meglumine Sales by Region (2021-2032)
  3. 6.2.1 Global Gadoterate Meglumine Sales by Region (2021-2026)
  4. 6.2.2 Global Gadoterate Meglumine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gadoterate Meglumine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gadoterate Meglumine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gadoterate Meglumine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gadoterate Meglumine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gadoterate Meglumine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gadoterate Meglumine Revenue by Region
  1. 7.1 Global Gadoterate Meglumine Revenue by Region
  2. 7.1.1 Global Gadoterate Meglumine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gadoterate Meglumine Revenue by Region (2021-2026)
  4. 7.1.3 Global Gadoterate Meglumine Revenue by Region (2027-2032)
  5. 7.1.4 Global Gadoterate Meglumine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gadoterate Meglumine Revenue (2021-2032)
  8. 7.2.2 North America Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gadoterate Meglumine Revenue (2021-2032)
  11. 7.3.2 Europe Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gadoterate Meglumine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gadoterate Meglumine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gadoterate Meglumine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hengrui Medicine
  2. 8.1.1 Hengrui Medicine Company Information
  3. 8.1.2 Hengrui Medicine Business Overview
  4. 8.1.3 Hengrui Medicine Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
  6. 8.1.5 Hengrui Medicine Recent Developments
  7. 8.2 Guerbet Group
  8. 8.2.1 Guerbet Group Company Information
  9. 8.2.2 Guerbet Group Business Overview
  10. 8.2.3 Guerbet Group Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guerbet Group Gadoterate Meglumine Product Portfolio
  12. 8.2.5 Guerbet Group Recent Developments
  13. 8.3 GE Healthcare
  14. 8.3.1 GE Healthcare Company Information
  15. 8.3.2 GE Healthcare Business Overview
  16. 8.3.3 GE Healthcare Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GE Healthcare Gadoterate Meglumine Product Portfolio
  18. 8.3.5 GE Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadoterate Meglumine Value Chain Analysis
  2. 9.1.1 Gadoterate Meglumine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadoterate Meglumine Production Mode & Process
  6. 9.2 Gadoterate Meglumine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadoterate Meglumine Distributors
  9. 9.2.3 Gadoterate Meglumine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst